| Name |
Condias 25 mg filmom obložene tablete |
| Marketing Authorisation Number |
HR-H-887614036 |
| Active Substance |
sitagliptinklorid hidrat |
| Composition |
jedna tableta sadrži 25 mg sitagliptina u obliku sitagliptinklorid hidrata |
| Pharmaceutical Form |
Filmom obložena tableta |
| Manufacturer |
Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder |
Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date |
24.06.2024 |
| MA Period of Validity |
24.06.2029 |
| Classification Number |
UP/I-530-09/21-01/252 |
| Registration Number |
381-12-01/286-24-08 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
A10BH01 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
